Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2025 14:24 ET | Source: Hagens Berman Sobol Shapiro LLP

ATYR Shareholder Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman

SAN FRANCISCO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the...
October 31, 2025 14:21 ET | Source: Hagens Berman Sobol Shapiro LLP

Fiserv, Inc. (FI) Former CEO Sold 2.6M Shares For $423M Before Company’s “‘Abysmal’” Q3 2025 Results – Hagens Berman

SAN FRANCISCO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Filings with the SEC reveal that Social Security Administration Commissioner Frank Bisignano, the former chairman and CEO of Fiserv, sold...
October 31, 2025 14:05 ET | Source: Hagens Berman Sobol Shapiro LLP

James Hardie Industries (JHX) Lawsuit Alleges Securities Fraud Over Inventory Misstatements – Hagens Berman

SAN FRANCISCO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX), the dominant producer of fiber cement building materials in...
October 31, 2025 14:01 ET | Source: Hagens Berman Sobol Shapiro LLP

MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate – Hagens Berman

SAN FRANCISCO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake...
October 29, 2025 18:37 ET | Source: Hagens Berman Sobol Shapiro LLP

Stride, Inc. (LRN) Plunges 49% as Platform Upgrade Fails, Triggering Hagens Berman Probe-- Hagens Berman

SAN FRANCISCO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Prominent shareholder rights law firm Hagens Berman is investigating Stride, Inc. (NYSE: LRN), the online education platform, for potential...
October 29, 2025 18:29 ET | Source: Hagens Berman Sobol Shapiro LLP

Fiserv, Inc. (FI) Shares Tank Amid “‘Abysmal’” Q3 2025 Results –Hagens Berman

SAN FRANCISCO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Investors in payments processor Fiserv, Inc. (NYSE: FI) saw the price of their shares tank over $59 (-47%) after reporting what some analysts...
October 29, 2025 14:35 ET | Source: Hagens Berman Sobol Shapiro LLP

James Hardie Industries (JHX) Lawsuit Alleges Securities Fraud Over Inventory Misstatements -- Hagens Berman

SAN FRANCISCO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX), the dominant producer of fiber cement building materials in...
October 29, 2025 13:36 ET | Source: Hagens Berman Sobol Shapiro LLP

MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman

SAN FRANCISCO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake...
October 29, 2025 12:44 ET | Source: Hagens Berman Sobol Shapiro LLP

aTyr Pharma, Inc. (ATYR) Securities Class Action Filed; Class Period Significantly Enlarged -- Hagens Berman

SAN FRANCISCO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the...
October 27, 2025 18:22 ET | Source: Hagens Berman Sobol Shapiro LLP

Organon & Co. (OGN) Faces Investor Scrutiny Amid Improper Wholesale Sales Practices, Abrupt CEO Departure -- Hagens Berman

SAN FRANCISCO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- On October 27, 2025, investors in Organon & Co. (NYSE: OGN) saw the price of their shares plummet $2.10 (-23%) after the company announced the...